Gary Howes - McDermott Will & Emery


Gary Howes has nearly 25 years of experience advising clients in the life sciences sector on the myriad legal issues that affect this key industry. Gary advises clients on industry specific commercial contracts, patent licensing agreements, alliances, collaborations and technology transfers, IP and regulatory matters and product acquisitions and disposals.

Show More


  • Representing a major global pharma company on various clinical and commercial arrangements
  • Representing an oncology focused autologous cell therapy company in its commercial and clinical arrangements
  • Representing an oncology focused biotechnology company on all its licensing and commercial agreements, including a global alliance with a major global pharma company which when completed was among the most significant of its kind

Show More


  • Chambers UK 2021 to 2023, ranked within Life Sciences: Transactional and described as “very personable” and an “insightful lawyer who is very knowledgeable about the biotech sector.
  • Chambers UK 2009 to 2016, listed as ‘Leader in their field’ within Life Sciences: Transactional and Life Sciences: Commercial/Corporate and described as a “marvel in commercial agreements” and noted for “his incisive intellectual ability to reduce problems” and “ability to communicate well with laymen in non-legal terms
  • The Legal 500 UK 2022, Recommended in Life Sciences and Healthcare
  • The Best Lawyers in the United Kingdom, Life Sciences Law, 2009 – 2024
  • Who’s Who Legal: Life Sciences 2021, Transactional
  • The Legal 500 UK 2011, 2013, 2014, 2015, TMT – Pharmaceuticals and biotechnology
  • The Legal 500 UK 2017 recommended in Corporate and Commercial: M&A – mid-market & Private Equity mid-cap

Show More


  • Bio Industry Association


University of Auckland, LLB, 1986

England and Wales, 1992
New Zealand, 1987